Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) for intermediate-risk PCa, aiming to selectively target localized cancerous lesions while preserving healthy
tissueFedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) a and miR-663b in 25 paired
tissue samples from patients with an established diagnosis of ovarian
. Methods: The GSE24265 dataset, consisting of data from four perihematomal brain
tissues and seven
Valeeva, Diana,
Akhiiarova, Karina,
Minniakhmetov, Ildar,
Mokrysheva, Natalia,
Khusainova, Rita,
Tyurin, Anton (2025) Background: Osteogenesis imperfecta (OI) is a rare monogenic connective
tissue disorder
determined the activation of retroelements in joint
tissues and in peripheral blood of patients
, derived from adipose
tissue through enzymatic digestion, is a heterogeneous mixture of cells, including